SNXFX
Price
$129.23
Change
+$1.39 (+1.09%)
Updated
Dec 24 closing price
VTSAX
Price
$144.66
Change
+$1.55 (+1.08%)
Updated
Dec 24 closing price
Ad is loading...

SNXFX vs VTSAX

Header iconSNXFX vs VTSAX Comparison
Open Charts SNXFX vs VTSAXBanner chart's image
Schwab 1000 Index®
Price$129.23
Change+$1.39 (+1.09%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.66
Change+$1.55 (+1.08%)
VolumeN/A
CapitalizationN/A
SNXFX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SNXFX vs. VTSAX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNXFX is a StrongBuy and VTSAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.84T vs. SNXFX (18.3B). VTSAX pays higher dividends than SNXFX: VTSAX (1.35) vs SNXFX (1.28). SNXFX was incepted earlier than VTSAX: SNXFX (34 years) vs VTSAX (24 years). SNXFX is a more actively managed with annual turnover of: 3.00 vs. VTSAX (2.00). SNXFX has a lower initial minimum investment than VTSAX: SNXFX (0) vs VTSAX (3000). SNXFX (26.77) and VTSAX (25.73) have marching annual gain over last year. SNXFX return over 5 years is better than : 86.47 vs. VTSAX (81.67).
SNXFXVTSAXSNXFX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence34 years24 years-
Gain YTD26.37425.370104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets18.3B1.84T1%
Annual Yield % from dividends1.281.3595%
Returns for 1 year26.7725.73104%
Returns for 3 years27.8124.29115%
Returns for 5 years86.4781.67106%
Returns for 10 years154.84187.5783%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK10.660.40
+3.90%
CleanSpark
STEL28.770.11
+0.38%
Stellar Bancorp
DOW40.090.12
+0.30%
Dow
MG8.77-0.12
-1.35%
Mistras Group
SABS4.10-0.18
-4.21%
SAB Biotherapeutics